TMTPOST — Insilico Medicine will be included in the MSCI Global Small Cap Index, the company said in a Hong Kong Stock Exchange filing. The index tracks the performance of small-capitalization companies across developed and emerging markets spanning a broad range of industries. The inclusion takes effect after the market close on Aug. 31. Since listing in Hong Kong, Insilico Medicine has already been added to several major index series, including CSI, Hang Seng and FTSE benchmarks. The board said the latest MSCI addition is expected to raise the company’s visibility among international institutional investors, attract passive fund inflows tracking the index, diversify its shareholder base and improve share trading liquidity.